Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,274,151
  • Shares Outstanding, K 177,557
  • Annual Sales, $ 114,620 K
  • Annual Income, $ -440,670 K
  • 60-Month Beta 2.24
  • Price/Sales 27.25
  • Price/Cash Flow N/A
  • Price/Book 2.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.75
  • Number of Estimates 8
  • High Estimate -0.50
  • Low Estimate -0.88
  • Prior Year -0.68
  • Growth Rate Est. (year over year) -10.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.63 +35.29%
on 03/16/20
18.94 -2.64%
on 03/19/20
-1.27 (-6.44%)
since 03/06/20
3-Month
13.63 +35.29%
on 03/16/20
28.60 -35.52%
on 01/13/20
-3.32 (-15.26%)
since 01/08/20
52-Week
13.63 +35.29%
on 03/16/20
37.00 -50.16%
on 04/12/19
-17.54 (-48.75%)
since 04/08/19

Most Recent Stories

More News
Why Is Nektar (NKTR) Down 16.1% Since Last Earnings Report?

Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NKTR : 18.44 (+4.83%)
Nektar Therapeut has the Best Relative Performance in the Pharmaceuticals Industry (NKTR , MYL , ZGNX , PCRX , PRGO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MYL : 15.14 (+5.36%)
NKTR : 18.44 (+4.83%)
ZGNX : 24.46 (+2.69%)
SmarTrend Watching for Potential Pullback in Shares of Nektar Therapeut After 13.98% Gain

Nektar Therapeut (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $15.92 to a high of $18.94. Yesterday, the shares gained 14.0%, which took the trading range above the 3-day high...

NKTR : 18.44 (+4.83%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Omeros Corp (OMER , NKTR , AGN , PCRX , PBH )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

AGN : 181.08 (+1.58%)
NKTR : 18.44 (+4.83%)
OMER : 13.48 (+1.51%)
Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference

Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to present at the upcoming Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 9:20 a.m. Eastern...

NKTR : 18.44 (+4.83%)
Nektar (NKTR) Q4 Earnings & Revenues Top Estimates, Stock Up

Nektar (NKTR) reports encouraging fourth-quarter results. The company continues to progress with its pipeline candidates.

PFE : 34.60 (+2.95%)
LLY : 146.22 (+3.06%)
BMY : 58.25 (+2.37%)
NKTR : 18.44 (+4.83%)
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of 7.25% and 28.57%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

NKTR : 18.44 (+4.83%)
Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2019.

NKTR : 18.44 (+4.83%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Internation (ENDP , XENT , NKTR , RVNC , COLL )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

XENT : 10.98 (+15.34%)
NKTR : 18.44 (+4.83%)
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2019 on Thursday, February 27, 2020, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2019, on Thursday, February 27, 2020, after the close of U.S.-based financial markets....

NKTR : 18.44 (+4.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NKTR with:

Business Summary

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists...

See More

Key Turning Points

2nd Resistance Point 19.53
1st Resistance Point 18.99
Last Price 18.44
1st Support Level 17.67
2nd Support Level 16.89

See More

52-Week High 37.00
Fibonacci 61.8% 28.07
Fibonacci 50% 25.32
Fibonacci 38.2% 22.56
Last Price 18.44
52-Week Low 13.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar